Masimo (MASI) Financials: Revenue & Earnings

MASI$179.950.00 0.00%

$9.42B

Market Cap

124.97

P/E

30.02

Forward P/E

40

Score

AI Analysis

Snapshot

Masimo doesn’t screen as a clean setup today — Stocklytics 40/100 leaves more to prove. Under the hood: P/E 125.0, rich vs its own history, plus revenue compounding ~-8% annually over recent years. The main risk is an earnings miss that compresses the multiple before the thesis has time to play out.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

32
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

15
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

74
FCF Margin %–
Debt/Equity %–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Masimo Corporation (MASI) last printed $179.95. Equity value is $9.42B. Trailing earnings multiple 124.97. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$712.9M$790.25M$858.29M$937.84M$1.14B$1.24B$2.04B$2.05B$2.09B$1.53B

About

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Masimo (MASI) Financials: Revenue & Earnings

MASI price $179.95 0.00 0.00%

Ticker
MASI
Price
$179.95
Change
0.00 0.00%
Market cap ?
$9.42B
P/E ?
124.97
Forward P/E ?
30.02
Dividend yield ?
0.00%
Sector
Healthcare
Industry
Medical - Devices
Stocklytics score
40
Value
32
Quality
74
Growth
15

Stocklytics score rationale: value 32, quality 74, growth 15.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener